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a b s t r a c t
This work aimed to develop membranes made of regenerated keratin and ceramides (CERs) to match the
barrier property of the human stratum corneum in in vitro percutaneous absorption studies. The membrane
composition was optimized on the basis of the in vitro drug diffusion proﬁles of ibuprofen, propranolol and
testosterone chosen as model drugs on the basis of their different diffusion and solubility properties. The
data were compared to those obtained using human epidermis.
The ATR-FTIR and SEM analyses revealed that CERs were suspended into the regenerated keratin matrix,
even if a partial solubilization occurred. It resulted in the membranes being physically stable after exposure
to aqueous buffer and/ormineral oil and the ﬂuxes of ibuprofen and propranolol from these vehicles through
membranes and human skin were of the same order of magnitude. The best relationship with human
epidermis data was obtained with 180μm-thick membrane containing 1% ceramide III and 1% ceramide VI.
The data on the testosterone diffusion were affected by the exposure of the membrane to a water/ethanol
solution over a prolonged period of time, indicating that such an organic solvent was able to modify the
supermolecular organization of keratin and CERs.
The keratin/CER membranes can represent a simpliﬁed model to assay the in vitro skin permeability study
of small molecules.
c© 2012 Elsevier B.V. All rights reserved.
1. Introduction
Percutaneous absorption is an interdisciplinary topic which is rel-
evant to a number of divergent ﬁelds. Indeed, the knowledge of the
diffusion of a compound after skin contact is crucial for the evaluation
of the risk assessment of toxic substances, the safety of cosmetic in-
gredients and the design and optimization of pharmaceutical dosage
forms as well as medical devices, to be applied onto the skin.
One option to predict the absorption of a compound through the
skin by in vitro diffusion tests is the use of diffusion cells in which
a donor and an acceptor compartment are separated by a suitable
membrane [1,2]. Human skin supplied from surgery or cadaver is
considered as the “gold-standard” because of the high correlation be-
tween in vitro and in vivo data [3]. Nevertheless, the human skin can-
not be readily available and presents large intra- and inter-individual
variations up to 45% [4,5]. The quest to circumvent these issues has
prompted the research on alternative membranes of mammalian ori-
gin. However, differences in stratum corneum thickness, number of
corneocyte layers, hair density, water content, lipid proﬁle and mor-
phology cause animal skin to be more permeable than human skin
leading to overemphasis of the compound permeability with respect
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to the human stratum corneum [3,6].
As an alternative, efforts have been made to develop membranes
of non-biological origin. Because of the negligible barrier-forming
properties of simple polymeric membranes, the comprehension of
the role played by the stratum corneum components in the diffusion
process is crucial in order to develop predicting in vitro assays.
Stratum corneum consists of protein-enriched cells (corneo-
cytes with corniﬁed envelope and cytoskeletal elements) and lipid-
enriched intercellular domains. Keratins are major structural pro-
teins in corneocytes forming a cytoplasmic network of 10–12-nm-
wide intermediate ﬁlaments [7–9]. In particular, intermediate ﬁla-
ments constituting up to 70% of the total dry weight mass of the stra-
tum corneum are coassembles of basic subunits (i.e. type I keratin)
and acidic subunits (i.e. type II keratin) having an average molecular
weight ranging from50 to70kDa [9].Moreover, keratins are classiﬁed
on the basis of the sulphur content which reﬂects the cross-linking
extent and, therefore, its resistance. Due to the low sulphur content,
in stratum corneum “soft-keratin” is present. A further classiﬁcation
is based on x-ray diffraction patterns obtained from different keratin
proteins. Alpha-helixes appear to be the basis of ﬁbrillar elements in
keratins from mammalians [8].
The continuous lipid bilayer is made of various classes of lipids,
namely cholesterol, cholesterol esters, free fatty acids, triglycerides
and ceramides (CERs), which are arranged in two coexisting lamellar
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phases; a long periodicity phasewith a repeat distance of about 13nm
and a short periodicity phase with a repeat distance of about 6nm
[10,11]. In particular, CERs have drawnmuch attention since changes
in the CER composition play a role in an impaired skin barrier [12,13].
The various CERs consist of a long-chain sphingoid base linked via
an amide bond to a fatty acid and, until now, twelve human CER
subclasses have been identiﬁed differing in polar head group and
chain length [14].
Because of the crucial role of the lipids in the skin barrier function,
an in vitromodel consisting of a porous substrate coveredwith a layer
of synthetic lipidswas proposed as a tool to predict solute permeation
throughhumanskin [15,16]. Abasic lipidmodelmembrane composed
of only four constituents was also prepared on porous substrates to
study the impact of each CER species on the diffusion and penetration
of drugs [17]. To match the permeability of the stratum corneum,
synthetic certramides, which are analogues of the ceramides, were
selected to develop a skin Parallel Artiﬁcial Membrane Permeability
Assay (PAMPA) model [18].
The presentwork aimed to develop amembranemade of a limited
number of CERs andkeratinwhich couldmimic thebarrier property of
thehuman stratumcorneum in in vitropercutaneous absorption stud-
ies. The membrane composition was optimized reducing the number
of components in order to simplify its preparation and favour the re-
producibility. The membrane performances were tested using three
model molecules chosen on the basis of their different diffusion and
solubility properties: (RS)-ibuprofen [19], (RS)-propranolol [20] and
testosterone [1]. The drug permeation amounts were compared to
those obtained in a set of experiments carried out using human epi-
dermis as membrane [1,2].
2. Materials and methods
2.1. Materials
(RS)-Ibuprofen (IB) and testosterone (TS) were obtained from
A.C.E.F. (Italy) and Sigma-Aldrich (Italy), respectively. (RS)-Propanolol
(PR) was kindly gifted by S.I.M.S. (Italy). Ceramide III, (N-stearyl-D-
erythro-phytosphingosine) equivalent to human ceramide 3 (CER 3),
and ceramide VI, (N-stearyl-2-hydroxy-D-erythro-phytosphingosine)
equivalent to human ceramide 7 (CER 6), were kindly gifted by Evonik
(The Netherlands). All solvents, unless speciﬁed, were of analytical
grade.
2.2. Keratin extraction
Keratin was extracted from Australian Merino wool, 19.5μmﬁne-
ness, by the sulphitolysis reaction, slightly modifying the extraction
methods described in previous works [21,22].
Brieﬂy, a ﬁbre sample, withdrawn from a combed sliver and
cleanedby Soxhlet extractionwithpetroleumether,waswashedwith
distilled water and conditioned at 20 ◦C, 65% R.H. for 24h. Five grams
of cleaned and conditionedﬁbreswas cut into snippets somemillime-
tres long, put in 100mL of aqueous solution containing urea (8M),
metabisulphite (0.5M) and sodium dodecyl-sulphate (SDS), adjusted
to pH 6.5 with NaOH 5N under strong mechanical shaking for 2h
at 65 ◦C using the Linitest apparatus. The Linitest consists of a water
reservoir containing a rotative axle with two stainless steel vessels
radially connected. The wool, immersed in the extraction solution, is
put in the two vessels with some steel bails and the axle rotates at a
frequency of 40±2 rpm. The water temperature is thermostatically
controlled and maintained constant during the test.
The mixture was ﬁltered with 5μm pore-size ﬁlter, using a peri-
staltic pump and dialyzed against distilled water using a cellulose
tube (6500Da molecular cut-off) for 3 days at room temperature,
changing distilled water four times a day.
The keratin aqueous solution obtained after dialysis was freeze-
dried in order to obtain a keratin powder.
2.3. Membrane preparation
Keratin membranes containing CER3 and CER6 in different ratios
(Table 1) were prepared as described below: CER3 and CER6 were
dispersed in formic acid using an ultrasound bath at the frequency
of 50Hz for 2h. Successively, the keratin powder was added to the
ceramides dispersion in order to obtain a solution at the keratin con-
centration of 5% w/w with respect to formic acid. The dissolution of
keratin powder was performed under shaking for 2h at room tem-
perature. Once keratin was dissolved, the solution was subjected to
ultrasonic treatment for 2h in order to remove air bubbles. The so-
lutions were cast in a 5×5 cm2 polyethylene mould at 50 ◦C until
constant weight. The mould was ﬁlled with 5, 7, and 10mL of solu-
tion, in order to obtain membranes having a thickness of about 60, or
140, or 180μm.
2.4. Membrane characterization
The molecular weights of keratin powder were determined by
electrophoresis SDS-PAGE. Before electrophoretic analysis, the ker-
atin powderwas dissolved in a reductive buffer of dithiothreitol/urea
at pH 8.6 under nitrogen atmosphere for 4h. SDS-PAGE was per-
formed according to Laemmli’s method [23] using XcellLockMini Cell
(Invitrogen, USA), on 12% polyacrilamide gels.
The dispersion of the ceramides in the keratin matrix was exam-
ined through transmitted lightmicroscopy (DM-LP Transmitted Light
Microscope, Leica, Italy).
The surface morphology and the cross sections of the membranes
obtained by fracture in liquid nitrogen were investigated by a LEO
435 VP scanning electron microscope (SEM) using an acceleration
voltage of 15 kV, a current probe of 400pA and a working distance
of about 24mm. Samples were sputter-coated with a gold layer 20–
30nm thick in rareﬁed argon, using an Emitech K550 sputter coater
with a current of 20mA for 240 s.
The thickness of themembraneswasmeasuredwith amicrometer
(MI 1000 micrometer, ChemInstruments, USA).
FTIR measurements were performed using a SpectrumTMOne
spectrophotometer (Perkin–Elmer, USA) by placing the keratinmem-
branes on a diamond crystal mounted on the ATR cell (Perkin–
Elmer, USA). The spectra recorded at 4 cm−1 resolution and 64 scans
were collected over the wavenumber region 4000–650 cm−1. After-
wards, the spectra were elaborated by ATR correction, and automatic
baseline corrected and smoothed with a nine-point Savitsky−Golay
function [24]. The resultant spectra upon second-derivative analy-
sis yielded the band maxima. Fourier self-deconvolution (FSD) of the
amide I band components (1705–1578 cm−1)was performedbyusing
Peakﬁt 4.12 software (Galactic Industries Corporation, New Hamp-
shire, USA). The amide I bands were resolved by the second-order
derivative with respect to the wavelength. Deconvolution was per-
formed using Gaussian line shape with an amplitude threshold of 3%.
A nonlinear least-squares method was ﬁnally used to take the re-
constituted curves as close as possible to the original deconvoluted
spectra. The ﬁtting results were further evaluated by examining the
residual from the difference between the ﬁtted curve and the original
curve and accepted when R2 was higher than 0.9900. The spectrum
of human epidermis was taken as a reference.
2.5. In vitro permeation studies
The skin used in the permeation studies was obtained from the
abdominal skin of three donors, who underwent cosmetic surgery
(30–50 years old, Eurasian females). Skin samples were prepared fol-
lowing the internal standard procedure [20]. The full-thickness skin
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Table 1
Fluxes (μg x h/cm2) of ibuprofen (IB), propranolol (PR) and testosterone (TS) through keratin membranes at different compositions and thicknesses.
Membrane Components (%, w/w) Thickness
(μm)
Vehicle IB PR TS
RK CER3 CER6 Flux FoD Flux Flux
1 100 – – 180 Water 9.26±0.04 2.51 – –
2 99 1.0 – 180 Water 0.34±0.00 0.09 – –
3 99 – 1.0 180 Water 1.20±0.34 0.32 – –
4 99 0.5 0.5 180 Water 4.15±0.15 1.13 – –
5 98 1.0 1.0 180 Water 2.97±0.12 0.80 – –
Physiologic solution – – 10.0±1.0 –
Mineral oil – – 8.7±3.0 –
Water/ethanol – – – 7.6±1.7
140 Water 4.05±0.08 1.10 – –
60 Water 6.40±1.59 1.73 – –
Human Water 3.69±1.69* – – –
epidermis Physiologic solution – – 17.9±4.3** –
Mineral oil – – 17.2±5.9** –
Water/ethanol – – – 3.8±0.8
∗ n = 12, three donors (Cilurzo et al., 2010a)
∗∗ n = 6, two donors.
was sealed in evacuated plastic bags and frozen at−20 ◦C within 24h
after removal.
Prior to experiments, the skin was thawed at room temperature,
and the excess of fat was carefully removed. The skin sections were
cut into squares of about 2.5 cm2 and, after immersing the skin in
water at 60 ◦C for 1min, the epidermis was gently separated from
the remaining tissue with forceps and carefully inspected by light
microscopy for any defects. Keratin membranes punched out at the
area of 2.5 cm2 were hydrated in MilliQ
®
water for 1h.
Afterwards, epidermis or membranes were mounted on the Franz
diffusion cell, the receptor compartment of which was ﬁlled with a
mixture of water/ethanol at the ratio 1:1 for TS [25], pH 7.4 PBS for
IB [19] and physiological solution for PR [20]. Special care was taken
to avoid air bubbles between the buffer and the epidermis in the
receptor compartment.
The upper and lower parts of the Franz cell were sealed with
Paraﬁlm
®
and fastened together by means of a clamp, with the epi-
dermis or membranes acting as seal between the donor and recep-
tor compartments. Then, the donor compartment was ﬁlled by an IB
saturated solution in MilliQ
®
water (0.5mL), or 1mL PR saturated
solution in MilliQ
®
water (1mL) and mineral oil (1mL), or 4mg/mL
TS in water/ethanol at the ratio 1:1 (0.5mL) and closed. The system
was kept at 37±1 ◦C by means of a circulating water bath so that
the epidermis surface temperature was at 32±1 ◦C throughout the
experiment.
At predetermined times (1, 2, 4, 6, 24h) aliquots of 0.2mL were
withdrawn fromthe receiver compartment and immediately replaced
with fresh receiver medium. The samples were directly assayed by
HPLC to determine the drug concentrations. All values represent the
averages of parallel experiments performed in triplicate.
The cumulative amount permeated through the skin per unit area
was calculated from the concentration of each substance in the re-
ceiving medium and plotted as a function of time. The steady ﬂux ( J)
was determined as the slope of the linear portion of the plot.
To avoid experimental errors due to inter-individual variability,
the drug ability to permeate human skin epidermis was evaluated
using epidermis sheets from a single donor.
2.6. HPLC methods
The drug concentration was determined by HPLC assay (HP 1100,
Chemstations, Agilent Technologies, USA).
RS-Ibuprofen: injection volume: 20μL; ﬂow rate: 1.5 mL/min; UV
absorbance: 225nm; column: C18 reverse-phase column C18 Nova-
Pak, 4.6 × 150mm2 (Waters, USA); mobile phase: acetonitrile:water
acidiﬁed by phosphoric acid at pH 2.6 at the ratio 60:40 (%, v:v);
temperature: 25 ◦C [26].
A standard calibration curve (1–50μg/mL) was used. The limit of
quantiﬁcation was 0.2μg/mL.
RS-Propranolol: injection volume: 20μL; ﬂowrate: 1.0mL/min;UV
absorbance: 225nm; column: C18 reverse-phase Bondclone, 10μm,
3.9 × 300mm2 (Phenomenex, USA); mobile phase: acetonitrile/0.2%
phosphoric acid at the ratio 30:70 (%, v:v); temperature: 25 ◦C [20].
Three standard calibration curves (0.005–5μg/mL; 1–40μg/mL;
10–200μg/mL) were used. The limit of quantiﬁcation was 0.004μg/
mL.
Testosterone: injection volume: 50μL; ﬂow rate: 1.2mL/min; UV
absorbance: 259nm; column: C18 reverse-phase LiChrospher
®
100
100/RP-18, 5μm, 125 × 4mm2 (CPS Analitica, Italy); mobile phase:
methanol/water at the ratio 70:30 (%, v:v); temperature: 30 ◦C.
A standard calibration curve (0.05–51μg/mL) was used [27].
2.7. Statistical analysis
Tests for signiﬁcant differences between means were performed
by oneway-ANOVA. Multiple comparison tests were carried out with
Bonferroni–Holm’s test. Differences were considered signiﬁcant at
the p<0.05 level.
3. Results and discussion
3.1. Regenerated keratin and membrane
Keratin extractionmay take place only after cleavage of disulphide
bonds and this can be achieved by oxidation, reduction or sulphi-
tolysis [28]. Sulphitolysis describes the cleavage of a disulphide by
sulphite to give a thiol and an S-sulphonate anion (or Bunte salt)
RSSR + SO2−3 ↔ RS− + RSSO−3
By introducing in the extraction process a vigorous mechanical
shaking through the use of the Linitest apparatus, the keratin ex-
traction yield increases to 40% of the original wool weight. In order
to evaluate if the mechanical shaking induces protein degradation,
the molecular weight distribution of keratin, extracted as previously
described, was determined by electrophoresis SDS-PAGE. The elec-
trophoretic pattern of keratin powder (Fig. 1, line 1) shows the typical
molecular mass bands of wool: the two highmolecular mass bands at
55 and 45kDa, related to the low sulphur keratin and the lowmolecu-
lar mass bands between 20 and 9kDa related to the high sulphur ker-
atin. Therefore, the vigorousmechanical shaking does not degrade the
protein. The preparation of pure keratinmembranes from formic acid
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Fig. 1. SDS-PAGE; marker (line M), keratin powder (line 1), and keratin after casting
from formic acid solutions (line 2).
solutions was widely studied in a previous work [21]. Despite being a
good solvent for keratin, formic acid is also very aggressive and tends
to degrade the protein in few weeks. Therefore, after casting of the
solutions containing CERs themolecular weights of keratinwere con-
trolled (Fig. 1, line 2), in order to test if the combination of formic acid
and ultrasonic treatment introduced to remove air bubbles (whose
formation is promoted by the CERs presence) degrades the protein.
As can be seen in Fig. 1, line 2, only a negligible degradation of the
protein occurred.
Keratin membranes containing CER3 and CER6 in different ratios
were visually transparent with a smooth and homogeneous surface.
As an example, the morphology of Membrane 5 is reported in Fig.
2a. It can be observed that CERs were homogeneously dispersed in
the keratin matrix. Moreover, the fractured section (Fig. 2b) shows
the ceramide particles embedded in the keratin matrix and pores of
about 1μm. The presence of these pores, previously occupied by CERs,
suggests poor adhesion between CERs and keratin.
The supermolecular structure of regenerated keratin and the or-
ganization of CERs in themembranes were studied by ATR-FTIR spec-
troscopy. The ATR-FTIR spectrum of human epidermis was taken as
a reference in order to compare the lipid organization in the artiﬁcial
membranes.
As depicted in Fig. 3, the most relevant bands of stratum corneum
are related to the N–H stretching vibration giving rise to the amide A
band and the O–H stretching of lipids in the range 3200–3300 cm−1;
the CH3 and CH2 symmetric and asymmetric vibrations at 2920
and 2850 cm−1, respectively; the lipid ester carbonyl stretching at
1740 cm−1; the CO and N–H stretching of amide I and amide
II at 1650 and 1550 cm−1, respectively; and the CHX scissoring of
lipids backbone at 1470 cm−1. The spectrum of Membrane 1 (Fig.
3) shows the characteristic adsorption bands of regenerated ker-
atin, assigned mainly to the peptide bonds (–CONH–). The amide A
band (3282 cm−1) is connected with the stretching vibration of N–H
bonds; the amide I band occurring in the 1700–1600 cm−1 region is
connected mainly with the CO stretching vibration; the amide II
(1520 cm−1) is related to the N–H bending and C–H stretching vi-
bration and, ﬁnally, the amide III band occurs in the range of 1220–
1300 cm−1 and it results from in phase combination of C–N stretch-
ing and N–H plane bending vibrations. The intense peaks at 1195 and
1025 cm−1 are due to the asymmetric and symmetric stretching vi-
brations of the Bunte salts residues, respectively. Finally, the bands in
the 2950–2850 cm−1 regionwere due to the CH3 and CH2 asymmetric
and symmetric vibrations.
The spectra of the compositemembranes substantially overlapped
the keratin sample (Membrane 1), with the exception of the CH3 and
CH2 asymmetric and symmetric vibrations (Fig. 3). The shift of these
bands can be mainly due to the sum of contributes of both CERs and
keratin stretching vibrations. Other signals attributed to the presence
of CERs in membranes at different compositions were not clearly
detected, probably because of the low content.
Since Amide I band mainly reﬂects the CO stretching vibration
of both CERs and keratins, the deconvolution permits to evidence
the hidden peaks determining the single contributes to the spec-
tra and, therefore, the similarity to human epidermis. The decon-
voluted amide I spectra in terms of wavenumbers and assignments
are reported in Table 2 with reference to literature [29]. In the case
of the human epidermis sheets, 11 peak frequencies were identi-
ﬁed in FSD spectra. The band centered at about 1633 cm−1 was at-
tributed to the intramolecular β-sheet; the peak at 1699 cm−1 and
the bands in the 1613–1625 cm−1 region are due to intermolecular
β-sheets. By deconvoluting the region between 1667 and 1694 cm−1,
four bands were revealed and assigned to various types of turn struc-
tures, which represent the less ordered structure. The contribution of
the random coil conformationwas identiﬁed as two peaks centered at
about 1650 cm−1. The band assigned toα-helixwas centered at 1659–
1660 cm−1. The absorption peak at 1595 cm−1 was attributed to the
Hys-ring vibration or, more in general, to the keratin side chains. The
bands of the keratin membrane (Membrane 1, Table 2) were con-
sistent to those of human epidermis, with the exception of the peaks
assigned to CERswhichwere obviously absent. Twomembraneswere
obtained by using a single CER, and an additional band at 1614 cm−1
or 1612 cm−1 was revealed (Membranes 2 and 3, Table 2). The peak
frequencies were close to those of the commercial ceramides (CER3:
1611 cm−1; CER6: 1617 cm−1). In the deconvoluted spectra of mem-
branes prepared with both CERs, one or two peaks were detected at
1611 cm−1 and 1618 cm−1 with respect to the concentration of the
lipophilic compounds within the membranes (Membranes 4 and 5,
Table 2). The lack of the band attributed to CER6 in the spectrum of
Membrane 3 was attributed to the different intensity of the amide I
band in the commercial samples of CER3 and CER6, the latter being
signiﬁcantly lower.
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Fig. 2. Light microscopy (a) and scanning electron (b) micrographs of keratin membrane containing 1% w/w CER3 and 1% w/w CER6.
Table 2
Frequencies (cm−1) and assignments of deconvoluted amide I band for human skin and keratin membranes at different compositions.
Assignment Human epidermis Membrane
1 2 3 4 5
Hys-ring vibration 1596 1594 1595 1595 1595 1595
Ceramides 1611 – 1612* – 1611 1611
– 1618 – 1618**
β-sheet
intermolecular
1620 1621 1623 1627 1628 1629
β-sheet
intramolecular
1633 1632 1631 1631 1634 1635
Random coil 1644–1651 1645–1649 1644–1650 1643–1649 1644–1649 1642–1650
α Helix 1660 1660 1660 1658 1658 1658
Turn 1668 1668 1668 1668 1668 1668
1676 1674 1675 1674 1675 1674
1681 1682 1681 1681 1681 1682
1691 1695 1691 1691 1690 1694
∗ CER3: The peak is centred at 1613 cm−1.
∗∗ CER6: The peak is centred at 1617 cm−1. Two shoulders are present at 1607 and 1632 cm−1.
Table 3
CHx stretching vibrations (cm
−1) and assignments for raw ceramides, human skin and membranes at different compositions.
Assignments CER3 CER6 Human
epidermis
Membrane
1 2 3 4 5
Asym CH3 2955 2956 2956 2957 2957 2957 2958 2959
Asym CH2 2915 2915 2917 2923 2919 2920 2920 2923
Sym CH3 2873 2874 2872 2872 2873 2873 2873 2873
Sym CH2 2849 2849 2850 2855 2851 2851 2851 2853
Fig. 3. ATR-FTIR spectra of keratin membranes made of pure keratin (black line) and
containing1%w/wCER3and1%w/wCER6 (red line). The spectrumofhumanepidermis
(blue line) is also reported, as reference. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
The differences in wavenumber of asymmetric and symmetric
stretching vibrations of CH2 and CH3 in the spectra of Membranes
2–5 with respect to Membrane 1 (Table 3) were attributed to a mod-
iﬁcation of the CERs solid state after blending with the regenerated
keratin indicating apartial solubilizationwithin the keratin polymeric
network. Indeed, during themembranesproduction, CERsweremain-
tained in suspension, as conﬁrmed by the microscopic analysis of the
membranes and the possible rearrangement from the orthorhombic
structure toward the hexagonal one was unlikely.
3.2. In vitro diffusion studies
Theeffects ofmembrane composition and thickness on IBdiffusion
were reported in Table 1 and the similarity in ﬂuxes values were
compared to those of human epidermis from three different donors
(J1 = 6±1μg × h/cm2; J2 = 3±0μg × h/cm2; J3 = 2±0μg × h/cm2,
[20]) using the factor of difference value, FoD [30].
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Fig. 4. IB permeation proﬁle through keratin membrane containing 1% w/w CER3 and
1%w/wCER6 (solid line) with respect to human epidermis from three different donors
(dashed line).
The FoD value was calculated as follows:
F oD = Jm
J h
where Jm denotes the ﬂux through the artiﬁcial membrane and Jh
refers to the ﬂux through human epidermis.
It was suggested that an animal model represents a signiﬁcant
prediction for the human skin behaviour if its associated FoD value is
less than three [30]; in this set of experiments this value was reduced
to the 0.5–1.5 range.
Membranes made only by regenerated keratin showed weak bar-
rier properties and the IB ﬂux was overestimated. Indeed, the ﬂux
was twicewith respect to humanepidermis and this valuewas signiﬁ-
cantly higher also according to the Bonferroni–Holmpost hoc analysis
(p = 0.002) with respect to those obtained by human epidermis.
By adding 1% of a single CER in Membranes 2 and 3, the IB ﬂux
signiﬁcantly decreased with respect to the membrane of pure keratin
(p < 0.001) and the drug permeated amounts were in the same order
of magnitude to human epidermis (p > 0.02; Table 1). Despite the
underestimation, these data conﬁrmed the fundamental role played
byCERs in thedesignof artiﬁcialmembranesandalso that thephysical
dispersion of these components within the keratin membrane was
sufﬁcient to contribute to the reduction of the IB diffusion.
The combination of both CERs at the concentration of 0.5% and 1%
w/w improved the IB permeated amount (Table 1). Indeed, the ﬂux of
bothmembranes was statistically different to those containing only a
single type of CERs (p> 0.001) and comparable to those of human epi-
dermis ( p > 0.56). Three specimens of Membrane 5 provided repro-
ducible data in terms of amount of permeated drug at each time point
and the proﬁles obtained by human epidermis from three different
donors and keratin membranes were superimposable (Fig. 4). Hence,
Membrane 5 containing 1% of both CERs was considered worthy of
further investigation. In particular, attention was focused on the ef-
fect of thickness, namely 60, 140 and 180μm. As expected the thicker
the membrane, the lower the ﬂux (Table 1), as evidenced by the FoD
trend. Nevertheless, according to the Bonferroni–Holm post hoc anal-
ysis, the ﬂuxes were not statistically different to those obtained with
human epidermis ( p > 0.08) or the 180μm-thick membranes.
Because of the ease of handling, the 180μm-thick membranes
were considered worthy to predict the permeability of IB. Its versatil-
ity was further investigated using other two drugs, namely PR and TS.
The permeation proﬁles of PR from both physiological solution and
mineral oil were superimposable to those of human epidermis (Fig. 5
a and b) and the FoD values were 0.56 and 0.51 for PR in physiological
solution and mineral oil, respectively, demonstrating the membrane
Fig. 5. Permeation proﬁles of PR from (a) physiological solution and (b) mineral oil
through keratin membrane containing 1% w/w CER3 and 1% w/w CER6 (solid line)
with respect to human epidermis (dashed line).
Fig. 6. TS permeation proﬁle through keratin membrane containing 1% w/w CER3
and 1% w/w CER6 (solid line) with respect to human epidermis (dashed line).
resistance in the presence of mineral oil. The only difference was
represented by a slight delay in lag time (Fig. 5 a and b).
A different behavior was evidenced in the case of the permeation
proﬁle of TS from a water/ethanol solution. In this case, the diffusion
patterns through human epidermis and Membrane 5 resulted sim-
ilarly only in the early data points, namely 5h (Fig. 6). Afterwards
the diffusion of TS increased since Membrane 5 did not maintain its
integrity over a prolonged period of time. Indeed, at the end of the
permeation experiment the intensity of the main ATR-FTIR bands in
Membrane 5 decreased and their wavenumbers slightly shifted. It
may be assumed that ethanol affected the biophysical properties of
keratin membranes enhancing its ﬂuidity followed by a detrimental
effect on its stability. Hence, the current membrane cannot be used
when organic solvents are selected as donor phase.
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4. Conclusion
The combination of regenerated keratin and CERs permitted the
development of simpliﬁed membranes of stratum corneum suitable
to match the diffusion of small molecules through human epider-
mis as demonstrated by comparing the diffusion proﬁles of three
model drugs. Nevertheless, the preparation method did not permit
the production of membranes stable in presence of organic solvents,
such as ethanol, over a prolonged period of time. However, the ap-
proach of using regenerated keratin to scaffold the lipid components
of stratum corneum can permit the design of membranes with an
environment closer to the outermost layer of the epidermis with re-
spect to other proposed systems. As a matter of fact the latter consist
of porous substrates (i.e. ﬁlters) covered and/or embedded with lipid
systems [31,32,12] and therefore cannot take into account possible
interactions among the permeant and the protein domain of stratum
corneum.
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